Led · Equity · Jun 2026

Neuronostics develops BioEP, a clinically validated digital biomarker platform that analyses standard EEG recordings using eight predefined computational biomarkers and produces a report in under five minutes. The platform is UKCA-marked and ISO-13485 certified and has been validated across 15 NHS sites with over 1,000 recordings. NHS service evaluations are underway at multiple Trusts, including The Royal Wolverhampton NHS Trust and University Hospitals Dorset, and the company has a strategic partnership with Stratus to support scalable US deployment. Neuronostics plans to pursue FDA clearance (with a submission planned for 2026) and to extend the platform to provide brain fingerprints of treatment response in pharmaceutical trials. The company highlights clinical needs such as long diagnostic wait times, high misdiagnosis rates, and the high rate of inconclusive routine EEGs as drivers for its adoption.

Participated · Equity · Jun 2026

Circular11 develops manufacturing technology and products made from low-grade plastic waste, producing composite lumber used for fencing, furniture and landscaping for construction and estates. Its process involves collecting problematic plastic streams, shredding and chemically profiling materials, using machine learning to determine optimal formulations, conducting in-house strength testing, and extruding finished plastic lumber while tracking feedstocks and carbon via a digital operating system. The company positions its composites as lower-carbon, longer-life alternatives to timber and aims to divert plastic from incineration and landfill. Founded in 2021 and based in Dorset, Circular11 set up a full-scale recycling and manufacturing facility following a 2023 €578k raise and now intends to scale manufacturing with the proceeds of its €2.7 million round. It aims to recycle about 10,000 tonnes of low-quality plastic over the next two years and to create a scalable recycling technology that can be deployed globally.

Led · Seed · Apr 2026

The Little Loop operates a B2B2C clothing resale platform that connects consumers and retailers, enabling trade-ins of used garments for curated, quality-checked preloved items or partner-brand vouchers. The platform allows brands to offer take-back schemes directly from their own channels without running the operations in-house, supporting sustainability targets and creating new revenue streams. The business is currently focused on children’s clothing and is preparing to expand into adult fashion. The company highlights existing relationships with household names such as John Lewis and JoJo Maman Bébé. The Little Loop cites the UK clothing resale market as worth £7bn and forecasts that it will double by 2029, noting rising consumer adoption of pre-loved fashion. The recently raised funds will be used to accelerate technology development and hire key staff to support growth.

Participated · Equity · Mar 2026

Semarion is a University of Cambridge spin-out building the SemaCyte platform that combines materials engineering, microfabrication, and cell biology to enable adherent cells to be used as barcoded, assay-ready, automation-compatible reagents. Its technology lets researchers multiplex cell models, increase throughput, and generate richer datasets within existing laboratory workflows. The company reports adoption by several global pharmaceutical organisations, including top 10 pharma companies, and is running pilot programmes in the US and Europe. Semarion has collaborations with life sciences tools providers to integrate its platform into imaging, analysis, and automated liquid handling workflows. Financially, Semarion has raised $2.89 million in 2022 and an additional $3.8 million in the latest round to fund manufacturing scale-up, commercial growth, and expanded field support.

Participated · Seed · Jan 2026

SmartResilience offers an enterprise SaaS platform that uses machine learning, predictive modeling and spatial data analytics to evaluate asset-level vulnerability to physical climate hazards. Its tools aim to help organizations quantify, model and mitigate physical climate risks across their operational footprints. The company plans to use the £1.1 million injection to enhance its predictive analytics engine and to accelerate commercial go-to-market activities. The fundraising was positioned against regulatory drivers such as CSRD and TCFD/ISSB, which are increasing demand for automated physical risk modeling for corporate balance sheets. The articles do not disclose revenue, users, founding year, location, or prior funding metrics.